NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shandong Yingsheng Biotechnology Co., Ltd.

Shandong Yingsheng Biotechnology Co., Ltd.

Private
JinanHealthcare & Life Scienceshttp://ivdys.com/

Last Round

Series C

Mar 29, 2022

Total Funding Raised

$46M

Company Overview

Shandong Yingsheng Biotechnology Co., Ltd. is a biotechnology company that integrates R&D, production, sales, and third-party medical testing services for clinical mass spectrometry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

clinical mass spectrometryin-vitro diagnosticsIVDmedical diagnostic equipmentneonatal screeningnewborn screeningprecision medicineIVD reagent kitsLC-MSmolecular diagnosticsMDxlab automationthird-party medical testingclinical lab servicesmetabolomicsgenomicsICP-MStherapeutic drug monitoringTDM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shandong Yingsheng Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Shandong Yingsheng Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shandong Yingsheng Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 29, 2022
Series BNov 12, 2020

Shandong Yingsheng Biotechnology Co., Ltd. Investors

Notable investors and investment history

Shandong Yingsheng Biotechnology Co., Ltd. investors
InvestorRounds
Hillhouse InvestmentSeries B
YuanBio Venture CapitalSeries C
Huimei CapitalSeries C, Series B
CD CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 29, 2022

    $16M round led by CD Capital.

Shandong Yingsheng Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shandong Yingsheng Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shandong Yingsheng Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJinan
Employee Range22
Year Founded2009
Last FundingMar 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.